Syndax Pharmaceuticals, Inc. (SNDX)
23.81
-0.52
(-2.14%)
USD |
NASDAQ |
Apr 16, 16:00
23.80
-0.01
(-0.04%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Investing (Quarterly) : 81.58M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -322.77M |
| Vera Therapeutics, Inc. | 80.66M |
| Biogen, Inc. | -1.232B |
| Johnson & Johnson | -- |
| Tango Therapeutics, Inc. | -135.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -69.49M |
| Cash from Financing (Quarterly) | 5.917M |
| Free Cash Flow | -323.17M |
| Free Cash Flow Per Share (Quarterly) | -0.7961 |
| Free Cash Flow to Equity (Quarterly) | -69.54M |
| Free Cash Flow to Firm (Quarterly) | -59.95M |
| Free Cash Flow Yield | -15.67% |